16:03 Jun 02

Jubilant Pharmova Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
975.05
-12.50 (-1.27%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Jubilant Pharmova Ltd. Financials

Jubilant Pharmova Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
975.05
-12.50 (-1.27%)
16:03 Jun 02
Quality
image/svg+xml

43/100
Medium Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

5

Weakness

3

Opportunity

1

Threats

0

5.61 %

ROE %

2.56 %

ROA %

25.02

EPS

448.91

BVPS

4.81 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
6130.16 6281.73 6702.9 7234.5 8279.6
Operating Expenses +
4973.83 5505.48 5802.1 6060.8 7019.8
Raw Material
1550.32 1918.63 2062.5 2282.4 2633.4
Increase Decrease in Cost
-62.32 -40.7 78.2 34.6 10.9
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
2043.39 2166.02 2216 2267.9 2700.6
Miscellaneous Expenses
1845.68 1965.97 1927.8 2070.1 2301.1
Operating Profit
1156.33 776.25 900.8 1173.7 1259.8
Other Income
11.29 38.33 68.7 56.8 66
Depreciation
381.7 554.03 381.9 368.6 440.4
Interest
145.49 188.2 272.3 240.3 211.8
Profit before tax and exceptio..
640.43 72.34 315.3 621.6 673.6
Exceptional Items
0 -56.82 -168.9 359.5 -59.2
PBT
640.43 15.53 146.4 981.1 614.4
Provision for Taxation
217.43 92.66 97.8 144.3 216.6
Net Profit
423 -77.13 48.6 836.8 397.8
NET Profit after MI
413.94 -60.98 77.1 839.4 398.5
EPS
26 -3.83 4.86 52.99 25.08
Operating Profit Margin (%)
18.86 12.36 13.44 16.22 15.22
Net Profit Margin (%)
6.75 -0.97 1.15 11.6 4.81

Jubilant Pharmova Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: